GeneDx Holdings (WGS) Enterprise Value (2020 - 2025)
Historic Enterprise Value for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$155.1 million.
- GeneDx Holdings' Enterprise Value fell 3316.07% to -$155.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$155.1 million, marking a year-over-year decrease of 3316.07%. This contributed to the annual value of -$141.2 million for FY2024, which is 848.03% down from last year.
- Latest data reveals that GeneDx Holdings reported Enterprise Value of -$155.1 million as of Q3 2025, which was down 3316.07% from -$134.6 million recorded in Q2 2025.
- Over the past 5 years, GeneDx Holdings' Enterprise Value peaked at $236.1 million during Q1 2021, and registered a low of -$461.3 million during Q3 2021.
- In the last 5 years, GeneDx Holdings' Enterprise Value had a median value of -$141.2 million in 2024 and averaged -$163.6 million.
- Per our database at Business Quant, GeneDx Holdings' Enterprise Value crashed by 4036355.24% in 2021 and then surged by 6906.08% in 2022.
- Quarter analysis of 5 years shows GeneDx Holdings' Enterprise Value stood at -$400.6 million in 2021, then skyrocketed by 69.06% to -$123.9 million in 2022, then dropped by 5.01% to -$130.1 million in 2023, then decreased by 8.48% to -$141.2 million in 2024, then decreased by 9.84% to -$155.1 million in 2025.
- Its Enterprise Value stands at -$155.1 million for Q3 2025, versus -$134.6 million for Q2 2025 and -$159.2 million for Q1 2025.